These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15280156)

  • 1. PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.
    Li S; Basnakian A; Bhatt R; Megyesi J; Gokden N; Shah SV; Portilla D
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F990-8. PubMed ID: 15280156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity.
    Li S; Wu P; Yarlagadda P; Vadjunec NM; Proia AD; Harris RA; Portilla D
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F572-80. PubMed ID: 14612380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.
    Li S; Gokden N; Okusa MD; Bhatt R; Portilla D
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F469-80. PubMed ID: 15814532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrate prevents cisplatin-induced proximal tubule cell death.
    Nagothu KK; Bhatt R; Kaushal GP; Portilla D
    Kidney Int; 2005 Dec; 68(6):2680-93. PubMed ID: 16316343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney.
    Sheikh-Hamad D; Cacini W; Buckley AR; Isaac J; Truong LD; Tsao CC; Kishore BK
    Arch Toxicol; 2004 Mar; 78(3):147-55. PubMed ID: 14551673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilastatin attenuates cisplatin-induced proximal tubular cell damage.
    Camano S; Lazaro A; Moreno-Gordaliza E; Torres AM; de Lucas C; Humanes B; Lazaro JA; Milagros Gomez-Gomez M; Bosca L; Tejedor A
    J Pharmacol Exp Ther; 2010 Aug; 334(2):419-29. PubMed ID: 20435919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure.
    Ramesh G; Reeves WB
    Am J Physiol Renal Physiol; 2003 Oct; 285(4):F610-8. PubMed ID: 12865254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisomal proliferator-activated receptor-alpha protects renal tubular cells from doxorubicin-induced apoptosis.
    Lin H; Hou CC; Cheng CF; Chiu TH; Hsu YH; Sue YM; Chen TH; Hou HH; Chao YC; Cheng TH; Chen CH
    Mol Pharmacol; 2007 Nov; 72(5):1238-45. PubMed ID: 17671096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.
    Doi S; Masaki T; Arakawa T; Takahashi S; Kawai T; Nakashima A; Naito T; Kohno N; Yorioka N
    Transplantation; 2007 Jul; 84(2):207-13. PubMed ID: 17667812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury.
    Li M; Balamuthusamy S; Khan AM; Maderdrut JL; Simon EE; Batuman V
    Peptides; 2010 Apr; 31(4):592-602. PubMed ID: 20034524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure.
    Letavernier E; Perez J; Joye E; Bellocq A; Fouqueray B; Haymann JP; Heudes D; Wahli W; Desvergne B; Baud L
    J Am Soc Nephrol; 2005 Aug; 16(8):2395-402. PubMed ID: 15944338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan.
    Di Paola R; Esposito E; Mazzon E; Genovese T; Muià C; Crisafulli C; Malleo G; Sessa E; Meli R; Cuzzocrea S
    Shock; 2006 Nov; 26(5):477-84. PubMed ID: 17047518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomic study of cisplatin-induced nephrotoxicity.
    Portilla D; Li S; Nagothu KK; Megyesi J; Kaissling B; Schnackenberg L; Safirstein RL; Beger RD
    Kidney Int; 2006 Jun; 69(12):2194-204. PubMed ID: 16672910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin increases TNF-alpha mRNA stability in kidney proximal tubule cells.
    Ramesh G; Brian Reeves W
    Ren Fail; 2006; 28(7):583-92. PubMed ID: 17050242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding.
    Sugden MC; Bulmer K; Gibbons GF; Holness MJ
    Arch Biochem Biophys; 2001 Nov; 395(2):246-52. PubMed ID: 11697863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of renal endonuclease G by cisplatin is reduced in DNase I-deficient mice.
    Yin X; Apostolov EO; Shah SV; Wang X; Bogdanov KV; Buzder T; Stewart AG; Basnakian AG
    J Am Soc Nephrol; 2007 Sep; 18(9):2544-53. PubMed ID: 17675668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking tumor necrosis factor-alpha inhibits folic acid-induced acute renal failure.
    Wan B; Hao L; Qiu Y; Sun Z; Cao Q; Zhang Y; Zhu T; Wang H; Zhang Y
    Exp Mol Pathol; 2006 Dec; 81(3):211-6. PubMed ID: 16595132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Par-4 is a novel mediator of renal tubule cell death in models of ischemia-reperfusion injury.
    Xie J; Guo Q
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F107-15. PubMed ID: 16896190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein.
    Genovese T; Mazzon E; Di Paola R; Muià C; Crisafulli C; Malleo G; Esposito E; Cuzzocrea S
    Immunology; 2006 Aug; 118(4):559-70. PubMed ID: 16764691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
    Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
    Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.